574 related articles for article (PubMed ID: 17872473)
1. Leptin signaling and obesity: cardiovascular consequences.
Yang R; Barouch LA
Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
[TBL] [Abstract][Full Text] [Related]
2. Leptin and cardiovascular diseases.
Hou N; Luo JD
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
[TBL] [Abstract][Full Text] [Related]
3. Leptin and the clinical cardiovascular risk.
Singh M; Bedi US; Singh PP; Arora R; Khosla S
Int J Cardiol; 2010 Apr; 140(3):266-71. PubMed ID: 19944469
[TBL] [Abstract][Full Text] [Related]
4. Leptin and cardiovascular diseases.
Luo JD; Zhang GS; Chen MS
Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
[TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension and obesity--a dangerous combination].
Zakharieva S
Vutr Boles; 1999; 31(1):28-32. PubMed ID: 10847146
[TBL] [Abstract][Full Text] [Related]
6. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
[TBL] [Abstract][Full Text] [Related]
7. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics.
Karmazyn M; Purdham DM; Rajapurohitam V; Zeidan A
Trends Cardiovasc Med; 2007 Aug; 17(6):206-11. PubMed ID: 17662916
[TBL] [Abstract][Full Text] [Related]
8. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
Mallamaci F; Tripepi G; Zoccali C
J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
[TBL] [Abstract][Full Text] [Related]
9. Leptin resistance and obesity.
Enriori PJ; Evans AE; Sinnayah P; Cowley MA
Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():254S-258S. PubMed ID: 17021377
[TBL] [Abstract][Full Text] [Related]
10. Selective insulin and leptin resistance in metabolic disorders.
Könner AC; Brüning JC
Cell Metab; 2012 Aug; 16(2):144-52. PubMed ID: 22883229
[TBL] [Abstract][Full Text] [Related]
11. [Leptin--adipose tissue hormone and its role in cardiovascular diseases].
Racek-Król B
Pol Merkur Lekarski; 2006 Jun; 20(120):713-6. PubMed ID: 17007277
[TBL] [Abstract][Full Text] [Related]
12. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
Engeli S; Sharma AM
Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between estrogen and leptin signaling in the hypothalamus.
Gao Q; Horvath TL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E817-26. PubMed ID: 18334610
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular consequences of obesity.
Okerberg K; Hamilton Dougherty A
Curr Womens Health Rep; 2003 Apr; 3(2):110-5. PubMed ID: 12628080
[TBL] [Abstract][Full Text] [Related]
15. The adipocyte as an active participant in energy balance and metabolism.
Badman MK; Flier JS
Gastroenterology; 2007 May; 132(6):2103-15. PubMed ID: 17498506
[TBL] [Abstract][Full Text] [Related]
16. Ectopic fat and cardiovascular disease: what is the link?
Gastaldelli A; Basta G
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):481-90. PubMed ID: 20659791
[TBL] [Abstract][Full Text] [Related]
17. Leptin and its metabolic interactions: an update.
Anubhuti ; Arora S
Diabetes Obes Metab; 2008 Nov; 10(11):973-93. PubMed ID: 18284436
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of obesity and the risk for cardiovascular disease.
Soufi M; Sattler AM; Herzum M; Maisch B; Schaefer JR
Herz; 2006 May; 31(3):200-6. PubMed ID: 16770555
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
Gualillo O; González-Juanatey JR; Lago F
Trends Cardiovasc Med; 2007 Nov; 17(8):275-83. PubMed ID: 18021938
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin, Leptin and Cardiovascular Disorders.
Zhao S; Kusminski CM; Scherer PE
Circ Res; 2021 Jan; 128(1):136-149. PubMed ID: 33411633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
